Peptides - Compound guides
Kisspeptin
Kisspeptin is a signalling peptide that sits upstream of the reproductive hormone axis and is the subject of genuine academic human research. It is not an approved medicine.
Kisspeptin is a naturally occurring signalling peptide produced by specific groups of neurons in the hypothalamus. It is encoded by a gene originally called KISS1, and it acts on a receptor known as KISS1R, or GPR54. Several fragments of the parent molecule are biologically active, which is why the scientific literature refers to kisspeptin-54, kisspeptin-10 and other forms - these are different lengths of the same core sequence.
Its discovery as a reproductive regulator came from human genetics rather than drug development. In the early 2000s, researchers studying families with an inherited failure of puberty found mutations in the gene for its receptor. That observation reoriented the field, showing that this previously obscure peptide was essential to reproductive biology rather than peripheral to it. Much of the subsequent work has been academic physiology rather than product development.
How it is thought to work
Reproductive hormones in both sexes are governed by a three-tier control system usually called the hypothalamic-pituitary-gonadal axis. It is worth walking through it in order, because kisspeptin's position within it is the whole point.
At the top, neurons in the hypothalamus release gonadotropin-releasing hormone, GnRH, in pulses into a small dedicated blood supply running to the pituitary gland. In the middle, the pituitary responds to those GnRH pulses by releasing two hormones into the general circulation: luteinising hormone, LH, and follicle-stimulating hormone, FSH. At the bottom, LH and FSH act on the gonads - the ovaries or the testes - which respond by producing sex steroids and by carrying out the work of egg and sperm development. Those sex steroids then feed back on the hypothalamus and pituitary, damping or adjusting the signal above them. It is a loop, not a one-way chain.
Kisspeptin neurons sit above all of this. They are a principal input onto the GnRH neurons, and they are the point where information about the body's wider state - energy availability, steroid feedback, timing signals - is integrated and converted into the pattern of GnRH pulses. In other words, kisspeptin is upstream of the axis rather than inside it. That position is what makes it scientifically interesting: acting at the top of a control system that has its own feedback intact is a different proposition from injecting a downstream hormone and overriding the loop. Researchers describe it as a way of studying the axis with its own regulation still in place.
What the research actually shows
Kisspeptin has a genuine, good-quality human research literature, which sets it apart from most compounds sold in the same corner of the internet. A substantial body of that work has come from academic groups in the UK, notably at Imperial College London, alongside centres elsewhere, and it is published in mainstream endocrinology and clinical research journals.
That research has been principally physiological and investigational. Studies have examined how administering kisspeptin affects the release of LH and FSH in human volunteers, how those responses differ between men and women and across the menstrual cycle, and how the system behaves in people with disorders of the reproductive axis. Other work has explored its use as a probe of axis function in research settings, and has examined responses within assisted reproduction protocols under formal trial conditions.
What this literature establishes is that kisspeptin is a real and important regulator of the human reproductive axis, and that its effects on hormone release can be measured in controlled research settings. What it does not establish is a treatment. There is no approved kisspeptin medicine, no defined therapeutic use, and no regulator has assessed a kisspeptin product for any indication. Research characterising a physiological signal and evidence supporting a therapy are different rungs of the ladder, and this one is on the former.
Where the evidence stops
- The human work is investigational physiology and early clinical research, not evidence of a licensed treatment for any condition.
- Studies have typically involved controlled, short-duration research administration under medical supervision. Long-term repeated exposure is not characterised.
- Different kisspeptin fragments behave differently, so findings using one form do not automatically describe another.
- The reproductive axis is tightly self-regulating, and how it adapts to sustained upstream stimulation over long periods is not established.
- Online claims presenting kisspeptin as a fertility treatment, a libido product or a testosterone strategy run far ahead of the published research, which does not support any such use.
Legal and regulatory status
Kisspeptin is not an approved medicine in the UK or, so far as licensing goes, anywhere else. It holds no marketing authorisation for any indication. Its legitimate use is within approved research studies, run under ethics committee oversight, with pharmaceutical-grade material and medical monitoring.
Material sold online is typically labelled as a research chemical and is not manufactured or tested to medicines standards. There is no regulatory oversight of its identity, purity, sterility or content, and the fact that a compound has a respectable academic literature says nothing whatsoever about the quality of a vial bearing its name. Reproductive hormone signalling is also a system with genuine potential for harm when interfered with, which is precisely why the research is done under supervision.
This lesson is educational content only and is not medical advice. Kisspeptin is not an approved medicine and is not established as a treatment for any condition, including anything relating to fertility or hormone levels. Nothing here is a recommendation to obtain or use it. Any concern about reproductive or hormonal health belongs with a qualified healthcare professional.
Reproductive-axis compounds
Start with the overview: How research peptides are grouped into families
Further reading
Sources for this classroom
Educational content only. Not medical advice, diagnosis or treatment. Always consult a qualified healthcare professional before changing your health regimen.
